Ken Fisher’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Ken Fisher’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,820	Closed	-$877K	–	1282
2023 Q2	$877K	Sell	22,820 -13,083	-36%	-$336K	﹤0.01%	802
2023 Q1	$831K	Sell	35,903 -8,100	-18%	-$193K	﹤0.01%	792
2022 Q4	$1.15M	Sell	44,003 -7,004	-14%	-$155K	﹤0.01%	746
2022 Q3	$1M	Buy	+51,007	New	+$1.02M	﹤0.01%	667

Ken Fisher's KDNY Position: Q3 2023 in Review

Ken Fisher sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 22,820 shares — an estimated $877K sold.

Ken Fisher first reported a position in KDNY in Q3 2022 and held it in 4 quarters. The position peaked at $1.15M in Q4 2022. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Ken Fisher reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Ken Fisher sold 22,820 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $877K.
Ken Fisher first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Ken Fisher's Chinook Therapeutics, Inc. Common Stock position peaked at $1.15M in Q4 2022.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.